Advertisement
Screener

ZAI LAB LIMITED (ZLAB) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ZAI LAB LIMITED Cash Flow Breakdown

Cash flow breakdown shows where ZAI LAB LIMITED's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $150.79M went out.
  • Fiscal year ended 2025-12-31: from investing, $307.87M came in.
  • Fiscal year ended 2025-12-31: from financing, $72.35M came in.
  • Fiscal year ended 2025-12-31: change in cash, $229.91M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$150.79M$307.87M-$8.22M$0.00$80.57M*$229.91M
2024-12-31-$214.87M-$375.19M$0.00$217.35M$132.54M*-$240.48M
2023-12-31-$198.18M-$10.78M-$8.80M$0.00$2.37M*-$218.01M
2022-12-31-$367.64M$420.02M-$7.60M$0.00$5.87M*$44.37M
2021-12-31-$549.23M$249.96M-$4.25M$7.42M$817.04M*$522.04M
2020-12-31-$216.06M-$554.83M$6.66M$1.13B*$366.42M
2019-12-31-$191.01M-$14.89M$1.05M$218.25M*$13.49M
2018-12-31-$97.54M-$212.55M$196.00K$143.95M*-$166.71M
2017-12-31-$32.37M-$10.43M$65.00K$187.79M*$145.71M
2016-12-31-$32.16M-$2.73M$106.20M*$70.79M
2015-12-31-$11.46M-$738.47K$18.28M*$6.01M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$63.41M*-$1.42M*-$2.20M*$946.00K*$19.96M*
2026-03-31-$11.91M-$22.29M-$2.27M$833.00K$7.01M*-$28.26M
2025-12-31-$26.02M*-$11.30M*$0.00*$249.00K*
2025-09-30-$32.04M*-$4.05M*-$8.19M*$1.98M*$27.00M*
2025-06-30-$31.02M*-$2.92M*-$27.00K*$8.44M*
2025-03-31-$61.70M$326.13M$0.00$3.01M$40.13M*$307.60M
2024-12-31-$55.77M*-$347.75M*$0.00*$1.88M*$235.93M*
2024-09-30-$26.82M*-$29.89M*$0.00*$1.28M*$40.93M*
2024-06-30-$42.17M*-$846.00K*$0.00*$44.00K*$22.28M*
2024-03-31-$90.11M$3.29M$0.00$0.00$47.55M*-$39.37M
2023-12-31-$14.92M*$14.46M*-$77.00K*$470.00K*
2023-09-30-$55.27M*-$13.98M*-$1.58M*$137.00K*
2023-06-30-$58.70M*$42.70M*-$2.06M*$565.00K*
2023-03-31-$69.29M-$53.95M-$5.08M$1.20M-$128.43M
2022-12-31-$109.29M*-$4.37M*-$429.00K*$230.00K*
2022-09-30-$126.32M*$568.26M*-$312.00K*$1.02M*
2022-06-30-$44.90M*-$113.72M*$4.32M*-$6.82M*
2022-03-31-$87.13M-$30.14M$297.00K-$117.14M
2021-12-31-$152.99M*-$281.49M*$510.00K*
2021-09-30-$160.89M*-$206.38M*$2.92M*
2021-06-30-$65.85M*-$4.18M*$3.29M*$817.93M*
2021-03-31-$169.50M$742.00M$702.00K*$571.30M
2020-12-31-$44.34M*$200.05M*$2.58M*$105.37M*
2020-09-30-$79.40M*-$748.36M*$1.01M*$741.98M*
2020-06-30-$52.48M*-$55.47M*$2.73M*-$713.00K*
2020-03-31-$39.84M$48.95M$346.00K$279.14M*$287.65M
2019-12-31-$40.02M*$49.64M*$607.63K*
2019-09-30-$67.81M*$41.49M*$143.37K*$517.41K*
2018-12-31-$44.63M*-$135.27K*$163.22K*$1.61M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67